References
- Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956-73. https://doi.org/10.1111/j.1574-6976.2008.00129.x
- Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther 2008;6:509-21. https://doi.org/10.1586/14787210.6.4.509
- Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998;62:1094-156.
- Denny FW, Clyde WA Jr, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis 1971;123:74-92. https://doi.org/10.1093/infdis/123.1.74
- Shimizu T, Kida Y, Kuwano K. Cytoadherence-dependent induction of inflammatory responses by Mycoplasma pneumoniae. Immunology 2011;133:51-61. https://doi.org/10.1111/j.1365-2567.2011.03408.x
- Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan TR, et al. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains. Am J Respir Crit Care Med 2010;182:797-804. https://doi.org/10.1164/rccm.201001-0080OC
- Chang HY, Jordan JL, Krause DC. Domain analysis of protein P30 in Mycoplasma pneumoniae cytadherence and gliding motility. J Bacteriol 2011;193:1726-33. https://doi.org/10.1128/JB.01228-10
- Rollins S, Colby T, Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med 1986;110:34-41.
- Vuori-Holopainen E, Salo E, Saxén H, Hedman K, Hyypiä T, Lahdenperä R, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis 2002;34:583-90. https://doi.org/10.1086/338642
- Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009;22:240-73. https://doi.org/10.1128/CMR.00046-08
- Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011;30:16-34. https://doi.org/10.3109/08830185.2010.529976
- Mühlradt PF, Kiess M, Meyer H, Sussmuth R, Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 1997;185:1951-8. https://doi.org/10.1084/jem.185.11.1951
- Zuo LL, Wu YM, You XX. Mycoplasma lipoproteins and Toll-like receptors. J Zhejiang Univ Sci B 2009;10:67-76. https://doi.org/10.1631/jzus.B0820256
- Narita M, Tanaka H, Yamada S, Abe S, Ariga T, Sakiyama Y. Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection. Clin Diagn Lab Immunol 2001; 8:1028-30.
- Hardy RD, Jafri HS, Olsen K, Wordemann M, Hatfield J, Rogers BB, et al. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun 2001;69:3869-76. https://doi.org/10.1128/IAI.69.6.3869-3876.2001
- Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev 2004; 15:157-68. https://doi.org/10.1016/j.cytogfr.2004.01.001
- Denny FW, Taylor-Robinson D, Allison AC. The role of thymusdependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol 1972;5:327-36. https://doi.org/10.1099/00222615-5-3-327
- Tanaka H, Honma S, Abe S, Tamura H. Effects of interleukin-2 and cyclosporin A on pathologic features in Mycoplasma pneumonia. Am J Respir Crit Care Med 1996;154(6 Pt 1):1908-12. https://doi.org/10.1164/ajrccm.154.6.8970385
- Lee KY, Rhim JW, Kang JH. Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. Med Hypotheses 2011;76:64-9. https://doi.org/10.1016/j.mehy.2010.08.032
- Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006;41:263-8. https://doi.org/10.1002/ppul.20374
- Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, et al. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr 2010;10:48. https://doi.org/10.1186/1471-2431-10-48
- Kim JW, Seo HK, Yoo EG, Park SJ, Yoon SH, Jung HY, et al. Mycoplasma pneumoniae pneumonia in Korean children, from 1979 to 2006- a meta-analysis. Korean J Pediatr 2009;52:315-23. https://doi.org/10.3345/kjp.2009.52.3.315
- Lee SH, Noh SM, Lee KY, Lee HS, Hong JH, Lee MH, et al. Clinicoepidemiologic study of Mycoplasma pneumoniae pneumonia (1993 through 2003). Korean J Pediatr 2005;48:154-7.
- Brunner H, Prescott B, Greenberg H, James WD, Horswood RL, Chanock RM. Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. J Infect Dis 1977;135:524-30. https://doi.org/10.1093/infdis/135.4.524
- Sasaki T, Kenri T, Okazaki N, Iseki M, Yamashita R, Shintani M, et al. Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene. J Clin Microbiol 1996;34:447-9.
- Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of communityacquired pneumonia. J Infect Chemother 2010;16:78-86. https://doi.org/10.1007/s10156-009-0021-4
- Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 2010;67:355-8. https://doi.org/10.1016/j.diagmicrobio.2010.03.004
- Dumke R, von Baum H, Lück PC, Jacobs E. Occurrence of macrolideresistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010;16:613-6. https://doi.org/10.1111/j.1469-0691.2009.02968.x
- Oh CE, Choi EH, Lee HJ. Detection of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae. Korean J Pediatr 2010;53:178-83. https://doi.org/10.3345/kjp.2010.53.2.178
- Hong KB, Lee SY, Choi EH, Lee J, Ahn YM, Lee HJ. Prevalence of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae in Korea. In: Program and abstracts of the 2011 Autumn Meeting of the Korean Society for Pediatric Infectious Diseases; 2011 Nov 12; Seoul: Korean Society of Pediatric Infectious Disease, 2011:7.
- Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother 2006;50:709-12. https://doi.org/10.1128/AAC.50.2.709-712.2006
- Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009;15:380-3. https://doi.org/10.1007/s10156-009-0715-7
- Narita M. Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae. J Infect Chemother 2011;17:735-6. https://doi.org/10.1007/s10156-011-0235-0
- Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest 2007;132:1962-6. https://doi.org/10.1378/chest.06-2415
- Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 2010;16:162-9. https://doi.org/10.1007/s10156-010-0044-x
- Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol 2005;43:2277-85. https://doi.org/10.1128/JCM.43.5.2277-2285.2005
- Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis 2010;29:1055-69. https://doi.org/10.1007/s10096-010-0975-2
- Martínez MA, Ruiz M, Zunino E, Luchsinger V, Avendaño LF. Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol 2008;57(Pt 12):1491-5. https://doi.org/10.1099/jmm.0.2008/003814-0
- Zhang L, Zong ZY, Liu YB, Ye H, Lv XJ. PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res 2011;134:270-80.
- Youn YS, Lee KY, Hwang JY, Yim JW, Kang JH, Lee JS. Comparison of diagnostic methods and the changes of IgG subclasses in children with Mycoplasma pneumoniae pneumonia. Pediatr Allergy Respir Dis 2009;19:137-45.
- Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI, Heijnen ML, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 2001;183:675-8. https://doi.org/10.1086/318529
- Shames JM, George RB, Holliday WB, Rasch JR, Mogabgab WJ. Comparison of antibiotics in the treatment of mycoplasmal pneumonia. Arch Intern Med 1970;125:680-4. https://doi.org/10.1001/archinte.1970.00310040104012
- McCracken GH Jr. Current status of antibiotic treatment for Mycoplasma pneumoniae infections. Pediatr Infect Dis 1986;5:167-71. https://doi.org/10.1097/00006454-198601000-00054
- Mulholland S, Gavranich JB, Chang AB. Antibiotics for communityacquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2010;(7): CD004875.
- Miyashita N, Maruyama T, Kobayashi T, Kobayashi H, Taguchi O, Kawai Y, et al. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. J Infect Chemother 2011;17:114-8. https://doi.org/10.1007/s10156-010-0093-1
- Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R. Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis 2011;17:1079-82. https://doi.org/10.3201/eid1706.101558
- Kosugi Y, Katsura H. A case of fulminant Mycoplasma pneumoniae pneumonia despite adequate antibiotic treatment. Nihon Kokyuki Gakkai Zasshi 2009;47:471-5.
- Kim DH, Lee KY, Kim MS, Youn YS, Hwang JY, Rhim JW, et al. Corticosteroid treatment in siblings affected with severe Mycoplasma pneumoniae pneumonia. Infect Chemother 2009;41:190-5. https://doi.org/10.3947/ic.2009.41.3.190
- Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 2008;57:223-8. https://doi.org/10.1016/j.jinf.2008.06.012
- Miyashita N, Obase Y, Ouchi K, Kawasaki K, Kawai Y, Kobashi Y, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 2007;56(Pt 12):1625-9. https://doi.org/10.1099/jmm.0.47119-0
- Lu A, Wang L, Zhang X, Zhang M. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid. Pediatr Pulmonol 2011;46:1093-7. https://doi.org/10.1002/ppul.21481
- Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis 2008;198:1180-8. https://doi.org/10.1086/591915
- Hirao S, Wada H, Nakagaki K, Saraya T, Kurai D, Mikura S, et al. Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. FEMS Immunol Med Microbiol 2011;62:182-9. https://doi.org/10.1111/j.1574-695X.2011.00799.x
Cited by
- Mycoplasma pneumoniaePneumonia Unresponsive to Macrolide Treatment vol.2, pp.4, 2012, https://doi.org/10.3343/lmo.2012.2.4.226
- Combination therapy with immune‐modulators and moxifloxacin on fulminant macrolide‐resistant Mycoplasma pneumoniae infection: A case report vol.48, pp.5, 2012, https://doi.org/10.1002/ppul.22650
- Treating paediatric community‐acquired pneumonia in the era of antimicrobial resistance vol.102, pp.suppl465, 2012, https://doi.org/10.1111/apa.12503
- Age-specific Mycoplasma pneumoniae pneumonia-associated myocardial damage in children vol.41, pp.5, 2012, https://doi.org/10.1177/0300060513497559
- A cross-sectional study of the clinical characteristics of hospitalized children with community-acquired pneumonia in eight eastern cities in China vol.13, pp.None, 2012, https://doi.org/10.1186/1472-6882-13-367
- Epidemiology of Lower Respiratory Tract Infections in Children vol.4, pp.2, 2013, https://doi.org/10.17795/compreped-10273
- Epidemiology of Lower Respiratory Tract Infections in Children vol.4, pp.2, 2012, https://doi.org/10.5812/jcp.10273
- Multiple-Locus Variable-Number Tandem-Repeat Analysis of Mycoplasma pneumoniae Clinical Specimens and Proposal for Amendment of MLVA Nomenclature vol.8, pp.5, 2012, https://doi.org/10.1371/journal.pone.0064607
- Indirect Particle Agglutination Antibody Testing for Early Diagnosis of Mycoplasma pneumoniae pneumonia in Children vol.20, pp.2, 2012, https://doi.org/10.14776/kjpid.2013.20.2.71
- Factors associated with various clinical manifestations ofMycoplasmapneumonia in children vol.1, pp.4, 2012, https://doi.org/10.4168/aard.2013.1.4.357
- Clinical differences according to radiological patterns in childhoodMycoplasma pneumoniaepneumonia vol.1, pp.4, 2012, https://doi.org/10.4168/aard.2013.1.4.362
- Score clínico para el descarte de neumonía por Mycoplasma pneumoniae vol.81, pp.4, 2012, https://doi.org/10.1016/j.anpedi.2013.11.024
- Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma vol.57, pp.6, 2012, https://doi.org/10.3345/kjp.2014.57.6.271
- Seroprevalences ofMycoplasma pneumoniaeIgM Antibodies among Children Living in Jeju Island, Korea vol.4, pp.3, 2014, https://doi.org/10.3343/lmo.2014.4.3.146
- Outbreaks of mumps: an observational study over two decades in a single hospital in Korea vol.57, pp.9, 2014, https://doi.org/10.3345/kjp.2014.57.9.396
- Dramatic decrease in fluoroquinolones in the pediatric population in Korea vol.23, pp.12, 2012, https://doi.org/10.1002/pds.3696
- Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study vol.46, pp.4, 2014, https://doi.org/10.3947/ic.2014.46.4.239
- Prevalence of Antibiotic Use for Pediatric Acute Upper Respiratory Tract Infections in Korea vol.30, pp.5, 2012, https://doi.org/10.3346/jkms.2015.30.5.617
- A Common Immunopathogenesis Mechanism for Infectious Diseases: The Protein-Homeostasis-System Hypothesis vol.47, pp.1, 2015, https://doi.org/10.3947/ic.2015.47.1.12
- Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years vol.58, pp.5, 2012, https://doi.org/10.3345/kjp.2015.58.5.172
- Pathogenesis and association of Mycoplasma pneumoniae infection with cardiac and hepatic damage vol.59, pp.7, 2015, https://doi.org/10.1111/1348-0421.12267
- New Research Progress in Mycoplasma pneumoniae Infection vol.4, pp.4, 2015, https://doi.org/10.1515/ii-2017-0114
- P40 and P90 from Mpn142 are Targets of Multiple Processing Events on the Surface of Mycoplasma pneumoniae vol.3, pp.4, 2015, https://doi.org/10.3390/proteomes3040512
- Clinical values of the early detection of serum procalcitonin, C-reactive protein and white blood cells for neonates with infectious diseases vol.32, pp.6, 2012, https://doi.org/10.12669/pjms.326.11395
- Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae vol.7, pp.None, 2012, https://doi.org/10.3389/fmicb.2016.00693
- Virus andMycoplasma pneumoniaeprevalence in a selected pediatric population with acute asthma exacerbation vol.53, pp.3, 2016, https://doi.org/10.3109/02770903.2015.1075548
- Early Serologic Diagnosis of Mycoplasma pneumoniae Pneumonia: An Observational Study on Changes in Titers of Specific-IgM Antibodies and Cold Agglutinins vol.95, pp.19, 2012, https://doi.org/10.1097/md.0000000000003605
- Kawasaki Disease with Influenza A Virus and Mycoplasma pneumoniae Infections: A Case Report and Review of Literature vol.23, pp.2, 2012, https://doi.org/10.14776/piv.2016.23.2.149
- Two case reports: Whole genome sequencing of two clinical macrolide-resistant Mycoplasma pneumoniae isolates with different responses to azithromycin vol.95, pp.38, 2012, https://doi.org/10.1097/md.0000000000004963
- Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children vol.13, pp.4, 2012, https://doi.org/10.1007/s12519-017-0014-9
- Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy vol.18, pp.2, 2017, https://doi.org/10.3390/ijms18020388
- A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system hypothesis vol.36, pp.2, 2017, https://doi.org/10.23876/j.krcp.2017.36.2.132
- Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children vol.60, pp.6, 2017, https://doi.org/10.3345/kjp.2017.60.6.167
- Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia vol.60, pp.8, 2012, https://doi.org/10.3345/kjp.2017.60.8.245
- ATF3 inhibits the inflammation induced by Mycoplasma pneumonia in vitro and in vivo vol.52, pp.9, 2012, https://doi.org/10.1002/ppul.23705
- Comparison of chemiluminescence immunoassay, enzyme-linked immunosorbent assay and passive agglutination for diagnosis of Mycoplasma pneumoniae infection vol.14, pp.None, 2012, https://doi.org/10.2147/tcrm.s159227
- Role of Probiotics in Mycoplasma pneumoniae Pneumonia in Children: A Short-Term Pilot Project vol.9, pp.None, 2012, https://doi.org/10.3389/fmicb.2018.03261
- Literature review and future strategies of childhood respiratory diseases in Korea vol.6, pp.suppl1, 2018, https://doi.org/10.4168/aard.2018.6.s1.s66
- Detecting Mycoplasma pneumoniae infections in nasopharyngeal specimens from Paediatric patients with asthma exacerbations in Baghdad: A Polymerase Chain Reaction – Gene based study vol.19, pp.2, 2012, https://doi.org/10.1016/j.ejmhg.2017.08.003
- Current usage and effects of steroids in the management of childhood mycoplasma pneumonia in a secondary hospital vol.6, pp.2, 2012, https://doi.org/10.4168/aard.2018.6.2.122
- Evaluation of the illumigene Mycoplasma Direct DNA Amplification Assay vol.56, pp.7, 2018, https://doi.org/10.1128/jcm.01930-17
- Mycoplasma pneumoniae : A Potentially Severe Infection vol.10, pp.7, 2018, https://doi.org/10.14740/jocmr3421w
- Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia vol.61, pp.8, 2012, https://doi.org/10.3345/kjp.2018.61.8.258
- Low‐dose versus high‐dose methylprednisolone for children with severe Mycoplasma pneumoniae pneumonia ( MCMP ): Study protocol for a randomized controlled trial vol.2, pp.3, 2012, https://doi.org/10.1002/ped4.12041
- Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children vol.33, pp.43, 2018, https://doi.org/10.3346/jkms.2018.33.e268
- Early Diagnosis of Mycoplasma pneumoniae in Children: Simultaneous Amplification and Testing (SAT) Is the Key vol.7, pp.None, 2012, https://doi.org/10.3389/fped.2019.00441
- Correlation between Cytokine and Chemokine levels and Clinical Severity in Children with Mycoplasma pneumoniae Pneumonia vol.26, pp.1, 2012, https://doi.org/10.14776/piv.2019.26.e6
- Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children vol.8, pp.5, 2019, https://doi.org/10.3390/jcm8050726
- Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children vol.62, pp.6, 2019, https://doi.org/10.3345/kjp.2018.07367
- Changes in the Treatment Strategies for Helicobacter pylori Infection in Children and Adolescents in Korea vol.22, pp.5, 2012, https://doi.org/10.5223/pghn.2019.22.5.417
- Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials vol.19, pp.None, 2012, https://doi.org/10.1186/s12890-019-0990-8
- Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China vol.8, pp.1, 2012, https://doi.org/10.1186/s13756-019-0576-5
- Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children vol.36, pp.2, 2012, https://doi.org/10.12669/pjms.36.2.1441
- Real-Time PCR and Quantitative Culture for Mycoplasma pneumoniae Load in Pharyngeal Swabs from Children at Preliminary Diagnosis and Discharge vol.2020, pp.None, 2012, https://doi.org/10.1155/2020/9814916
- 마행감석탕의 소아 마이코플라즈마 폐렴 치료에 대한 체계적 문헌 고찰 및 메타분석 vol.34, pp.2, 2012, https://doi.org/10.7778/jpkm.2020.34.2.90
- The solution on enigmas in COVID-19: the protein-homeostasis-system hypothesis vol.63, pp.7, 2012, https://doi.org/10.5124/jkma.2020.63.7.366
- Immunopathogenesis of COVID-19 and early immunomodulators vol.63, pp.7, 2012, https://doi.org/10.3345/cep.2020.00759
- A case of an unfavorable outcome of Мycoplasma pneumonia with the formation of fibrotic changes in the lungs in a child vol.19, pp.4, 2012, https://doi.org/10.22627/2072-8107-2020-19-4-64-68
- Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of Mycoplasma pneumoniae pneumonia in children : A protocol for systematic review and meta-analysis vol.99, pp.51, 2012, https://doi.org/10.1097/md.0000000000023747
- A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia vol.100, pp.44, 2012, https://doi.org/10.1097/md.0000000000027564
- Chest CT Findings and Differential Diagnosis of Mycoplasma pneumoniae Pneumonia and Mycoplasma pneumoniae Combined with Streptococcal Pneumonia in Children vol.2021, pp.None, 2012, https://doi.org/10.1155/2021/8085530
- Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae vol.12, pp.None, 2012, https://doi.org/10.3389/fmicb.2021.766591
- Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids vol.10, pp.6, 2012, https://doi.org/10.3390/jcm10061309
- Multiple anatomic sites of infarction in a pediatric patient with M. pneumoniae infection, a case report vol.21, pp.1, 2012, https://doi.org/10.1186/s12887-021-02845-3